6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
424B3 - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
YANGZHOU, China, Aug. 26, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that Xin "Steven" Wang, Chief Executive Officer of Meihua, will present and discuss recent corporate events at LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar on Wednesday, August 28, 2024, at 3:00 PM ET. Conference Details: Conference: LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar Date/Time: Wednesday, August 28, 2024, at 3:00 PM ET Presenter: Xin "Steven"
YANGZHOU, China, July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced that its NT-2000 surgical path analysis system successfully supported the world's second* 5G remote robot-assisted lobectomy. This procedure, we believe the first of its kind in China's Yangzi Delta area, was performed on July 15, 2024, at Yangzhou University Affiliated Hospital by a team from Shanghai Chest Hospital. "We are honored that our cutting-edge technology could assist the advanced 3D imaging for surgica
YANGZHOU, China, July 1, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors (the "Board") has approved and authorized a share repurchase program of up to $3 million of the Company's outstanding ordinary shares (the "Share Repurchase Program"). The Company intends to cancel all shares repurchased pursuant to this Share Repurchase Program. The ordinary shares may be repurchased from time to time through open market purchases or privately negotiated transactions at
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors (the "Board") has approved and authorized a share repurchase program of up to $3 million of the Company's outstanding ordinary shares (the "Share Repurchase Program"). The Company intends to cancel all shares repurchased pursuant to this Share Repurchase Program.
Gainers Deciphera Pharmaceuticals (NASDAQ:DCPH) stock rose 71.0% to $25.05 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Koninklijke Philips (NYSE:PHG) shares moved upwards by 40.91% to $29.69. The company's market cap stands at $26.9 billion. The company's, Q1 earnings came out today. Akanda (NASDAQ:AKAN) shares moved upwards by 25.63% to $0.13. The company's market cap stands at $1.5 million. XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 22.62% to $2.97. The market value of their outstanding shares is at $16.1 million. Scorpius Holdings (AMEX:SCPX) shares increased by 22.6% to $0.21. The company's market cap stands at $7.4 mill
YANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the appointments of Mr. Xin Wang as Chief Executive Officer and director, Mr. Lianzhang Zhao as Chief Financial Officer and Ms. Huijuan Zhao as independent board member, member of the compensation committee and audit committee, and chair of the nominating committee, effective as of December 1st, 2022, to fill the vacancies arising from the voluntary resignations of Mr. Yulin Wang as CEO, interim CFO and director of
YANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the appointments of Mr. Xin Wang as Chief Executive Officer and director, Mr. Lianzhang Zhao as Chief Financial Officer and Ms. Huijuan Zhao as independent board member, member of compensation committee and audit committee, and chair of nominating committee, effective as of December 1st, 2022, to fill the vacancies arising from the voluntary resignations of Mr. Yulin Wang as CEO, interim CFO and director of the Comp